Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Change in Accured Expenses (2010 - 2025)

Updated

Provectus Biopharmaceuticals (PVCT) reported Change in Accured Expenses of $337,094 for Q4 2025, down 45.4% from $617,160 a year earlier but up 67.8% from the prior quarter.

Analysis

Provectus Biopharmaceuticals (PVCT) Change in Accured Expenses (2010 - 2025) Analysis & Trends

For FY2025, Provectus Biopharmaceuticals posted Change in Accured Expenses of $986,003, down 7.6% from FY2024.

  • Change in Accured Expenses has a five-year compound annual growth rate of -10.8% (FY2020 to FY2025).
  • By year, Change in Accured Expenses came in at $1.07 million in FY2024 (+27.6%), $836,426 in FY2023 (+107.9%), $402,390 in FY2022 (-57.9%) and $956,834 in FY2021 (-45.3%).
  • Five-year quarterly Change in Accured Expenses spans a low of -$144,118 in Q1 2024 and a high of $617,160 in Q4 2024.
  • Year over year, Change in Accured Expenses gained in four of the last six quarters, with growth averaging 66.0%.
  • The high point for year-over-year Change in Accured Expenses in five years was Q4 2024 (growth of 237.7%); the low point was Q3 2021 (a decline of 99.6%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $200,929 (Q3 2025), $389,828 (Q2 2025) and $58,152 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,158.11 Bn 1,126.70 Bn 19.71 Bn -
2 Johnson & Johnson 636.97 Bn 556.83 Bn 17.30 Bn 2.41 Bn
3 AbbVie 501.44 Bn 474.55 Bn 12.70 Bn 1.20 Bn
4 Merck 357.35 Bn 311.73 Bn 12.21 Bn -
5 Novartis Ag 301.15 Bn 265.14 Bn 11.24 Bn -
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn -
7 Amgen 238.93 Bn 194.33 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.19 Bn 168.38 Bn 6.22 Bn 338.00 Mn
9 Pfizer 172.28 Bn 118.93 Bn 10.94 Bn -
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 337,094.00
Sep 30, 2025 200,929.00
Jun 30, 2025 389,828.00
Mar 31, 2025 58,152.00
Dec 31, 2024 617,160.00
Sep 30, 2024 301,710.00
Jun 30, 2024 292,129.00
Mar 31, 2024 -144,118.00
Dec 31, 2023 182,762.00
Sep 30, 2023 170,645.00
Jun 30, 2023 128,767.00
Mar 31, 2023 354,252.00
Dec 31, 2022 -39,965.00
Sep 30, 2022 113,220.00
Jun 30, 2022 146,134.00
Mar 31, 2022 183,001.00
Dec 31, 2021 14,577.00
Sep 30, 2021 2,045.00
Jun 30, 2021 452,250.00
Mar 31, 2021 487,962.00
API Access

Provectus Biopharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PVCT&period=max&api_key=YOUR_API_KEY